4WE0 Stock Overview Processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. More details
Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Entourage Health Corp. Competitors Price History & Performance
Summary of share price highs, lows and changes for Entourage Health Historical stock prices Current Share Price CA$0.001 52 Week High CA$0.018 52 Week Low CA$0.0005 Beta 1.3 1 Month Change 100.00% 3 Month Change 0% 1 Year Change 0% 3 Year Change -98.20% 5 Year Change -99.82% Change since IPO -99.84%
Recent News & Updates
Entourage Health Corp. to Report Q3, 2024 Results on Nov 28, 2024 Nov 21
Second quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.031 loss in 2Q 2023) Aug 27
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag May 09
Full year 2023 earnings released: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022) May 02 Entourage Health Corp. to Report Q1, 2024 Results on May 30, 2024
Entourage Health Corp., Annual General Meeting, Jun 12, 2024 Mar 29 See more updates
Entourage Health Corp. to Report Q3, 2024 Results on Nov 28, 2024 Nov 21
Second quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.031 loss in 2Q 2023) Aug 27
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag May 09
Full year 2023 earnings released: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022) May 02 Entourage Health Corp. to Report Q1, 2024 Results on May 30, 2024
Entourage Health Corp., Annual General Meeting, Jun 12, 2024 Mar 29
Insufficient new directors Feb 01
Entourage Health Corp. Announces Resignation of Lu Cacioppo from its Board of Directors Feb 01
Entourage Health Corp. Announces Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, Will Step Down, Effective December 18, 2023 Dec 06
Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.057 loss in 3Q 2022) Nov 29
Entourage Health Corp. to Report Q3, 2023 Results on Nov 27, 2023 Nov 09
Second quarter 2023 earnings released: CA$0.031 loss per share (vs CA$0.03 loss in 2Q 2022) Sep 01
Entourage Health Corp. Launches Dime Bag Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis Aug 25
Entourage Health Corp. to Report Q2, 2023 Results on Aug 29, 2023 Aug 10
An unknown buyer acquired Strathroy facility of Entourage Health Corp. Jun 21
Full year 2022 earnings released: CA$0.40 loss per share (vs CA$0.32 loss in FY 2021) May 03
Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.071 loss in 3Q 2021) Nov 17
High number of new and inexperienced directors Nov 16
Entourage Health Corp. to Report Q3, 2022 Results on Nov 14, 2022 Nov 09
Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products Oct 27
Entourage Health Corp. Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products from Collective of In-House and Third-Party Micro Producers Sep 28
Entourage Health Corp. Appoints James Afara to Chief Operating Officer Sep 17
Second quarter 2022 earnings released Aug 30
Entourage Health Corp. to Report Q2, 2022 Results on Aug 29, 2022 Aug 12
Entourage Health Corp. Expands Medical Offerings with Launch of New Services and Products Jul 27
Entourage Health Corp. to Report Q1, 2022 Final Results on May 30, 2022 May 21
Full year 2021 earnings released: CA$0.32 loss per share (vs CA$0.43 loss in FY 2020) May 11
High number of new and inexperienced directors Apr 27 Entourage Health Corp. Reaffirms Preliminary Unaudited Revenue Guidance for the Fiscal Year Ended December 31, 2021
Entourage Health Corp., Annual General Meeting, Jun 01, 2022 Mar 31
Entourage Health Corp., Annual General Meeting, Jun 01, 2022 Mar 30 Entourage Health Corp. Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team Mar 10
Entourage Health Corp. Appoints George Scorsis to Permanent Role of Chief Executive Officer Feb 12
Entourage Health Launches New Premium Color Cannabis Products Jan 28
Entourage Health Corp. announced that it has received CAD 50 million in funding from Labourers' Pension Fund of Central and Eastern Canada Dec 25
High number of new directors Dec 02
Third quarter 2021 earnings released: CA$0.071 loss per share (vs CA$0.12 loss in 3Q 2020) Nov 21
No longer forecast to breakeven Aug 12
First quarter 2021 earnings released Jul 01
Final Bell Canada Inc. acquired Starseed Medicinal Inc. from WeedMD Inc. (TSXV:WMD) for CAD 2.5 million Jun 16
Full year 2020 earnings released: CA$0.43 loss per share (vs CA$0.09 loss in FY 2019) Jun 03 WeedMD Inc. (TSXV:WMD) signed a Letter of Intent to acquire CannTx Life Sciences Inc. on May 31, 2021.
Forecast breakeven pushed back to 2022 May 22
Chief Financial Officer has left the company May 01
WeedMD Inc. has completed a Composite Units Offering in the amount of CAD 15 million. Mar 14
WeedMD Inc.'s Starseed Medicinal Announces the Release of Strain-Specific Products for Pax® Era® Vaporizer Feb 26
Weedmd Inc. Announces Mary’S Medicinals Topicals Product Release in Canada Feb 18
WeedMD Inc. Appoints Vincent Doré as Corporate Secretary Feb 02
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup Jan 21
WeedMD Enters into Sales, Marketing and Distribution Agreement with Rose LifeScience Inc Jan 15
WeedMD Inc. Reallocates All Medical Packaging, Labelling and Distribution Activities from its Bowmanville, Ontario Site to its Aylmer, Ontario Facility Jan 09 WeedMD Inc. Announces Executive Changes
WeedMD Inc. Launches Terpene-Infused Saturday Cannabis-Branded Vaporization Products Dec 19
Third quarter 2020 earnings released: EPS CA$0.04 Dec 02
WeedMD Inc. to Report Q3, 2020 Results on Nov 30, 2020 Nov 12
Weedmd Inc. Commences Shipping Its Color Cannabis-Branded 510 Vaporizer Cartridges to Ontario Cannabis Store Oct 29
WeedMD Inc. Appoints Lu Cacioppo to its Board of Directors Oct 20
WeedMD Announces Cannabis 2.0 Supply Partnership with Pax Labs® Oct 14
First half earnings released Oct 01
WeedMD Inc. to Report Q2, 2020 Results on Sep 30, 2020 Sep 25
WeedMD Inc. Secures Expanded Health Canada Licence to Sell All Cannabis Formats from Cultivation Facility Sep 22
New 90-day low - €0.21 Sep 10
WeedMD Inc. to Report Q2, 2020 Results on Sep 23, 2020 Aug 22
New 90-day low - €0.21 Jul 28 Shareholder Returns 4WE0 DE Pharmaceuticals DE Market 7D 100.0% -2.2% -2.0% 1Y 0% -15.6% 6.9%
See full shareholder returns
Return vs Market: 4WE0 underperformed the German Market which returned 6.9% over the past year.
Price Volatility Is 4WE0's price volatile compared to industry and market? 4WE0 volatility 4WE0 Average Weekly Movement 750.4% Pharmaceuticals Industry Average Movement 5.5% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 4WE0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 4WE0's weekly volatility has increased from 595% to 750% over the past year.
About the Company Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.
Show more Entourage Health Corp. Fundamentals Summary How do Entourage Health's earnings and revenue compare to its market cap? 4WE0 fundamental statistics Market cap €2.06m Earnings (TTM ) -€28.17m Revenue (TTM ) €27.70m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 4WE0 income statement (TTM ) Revenue CA$41.46m Cost of Revenue CA$37.23m Gross Profit CA$4.23m Other Expenses CA$46.40m Earnings -CA$42.16m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.14 Gross Margin 10.21% Net Profit Margin -101.69% Debt/Equity Ratio -105.2%
How did 4WE0 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 02:59 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Entourage Health Corp. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Shaan Mir Canaccord Genuity Daniel Pearlstein Eight Capital Neal Gilmer Haywood Securities Inc.
Show 1 more analysts 
